久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

US FDA issues emergency use authorization for first COVID-19 vaccine

Xinhua | Updated: 2020-12-12 14:08
Share
Share - WeChat
In this file photo illustration taken on Nov 23, 2020, shows a syringe and a bottle reading "COVID-19 Vaccine" next to the Pfizer company logo. [Photo/Agencies]

WASHINGTON -- The US Food and Drug Administration (FDA) Friday issued authorization for emergency use of the first COVID-19 vaccine in the United States.

The first Emergency Use Authorization (EUA) was issued to the COVID-19 vaccine of American drugmaker Pfizer in partnership with German company BioNTech, allowing the vaccine to be distributed in the United States.

The FDA has determined that Pfizer-BioNTech COVID-19 vaccine has met the statutory criteria for issuance of an EUA. The totality of the available data provides clear evidence that Pfizer-BioNTech COVID-19 vaccine may be effective in preventing COVID-19, said the FDA in a statement.

The data also show that the known and potential benefits outweigh the known and potential risks, supporting the vaccine's use in millions of people 16 years of age and older, said the FDA.

"The FDA's authorization for emergency use of the first COVID-19 vaccine is a significant milestone in battling this devastating pandemic that has affected so many families in the United States and around the world," said FDA Commissioner Stephen Hahn.

"Today's action follows an open and transparent review process that included input from independent scientific and public health experts and a thorough evaluation by the agency's career scientists to ensure this vaccine met FDA's rigorous, scientific standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization," he said in a statement.

The Pfizer-BioNTech vaccine contains a small piece of the SARS-CoV-2 virus's mRNA that instructs cells in the body to make the virus's distinctive "spike" protein.

When a person receives this vaccine, their body produces copies of the spike protein, which does not cause disease, but triggers the immune system to learn to react defensively, producing an immune response against SARS-CoV-2.

The vaccine is administered as a series of two doses, three weeks apart.

Global COVID-19 cases surpassed 70 million on Friday, according to the Center for Systems Science and Engineering at Johns Hopkins University. The United States reported the most cases and deaths around the world as of 4:28 pm local time (2128 GMT), numbering 15,758,661 and 293,785, respectively.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产精品日韩欧美在线 | 伊人久热这里只有精品视频99 | 毛片免费在线视频 | 欧美成人自拍视频 | 日本不卡不码高清免费观看 | 国产成人精视频在线观看免费 | 精品欧美一区二区三区在线 | 久久国产一区二区三区 | 日韩一级精品视频在线观看 | 欧美色欧美色 | 欧美成人精品大片免费流量 | 无码孕妇孕交在线观看 | 国产精品亚洲专一区二区三区 | 久久99精品久久久久久久不卡 | 自拍视频网 | 91精品久久国产青草 | 一级毛片aaa片免费观看 | 久久综合九色综合欧洲色 | 日韩特级片 | 国产午夜精品理论片在线 | 欧美午夜不卡 | 欧美成人高清手机在线视频 | 国产成人99久久亚洲综合精品 | 6080伦理久久精品亚洲 | 91久国产在线观看 | 国内主播福利视频在线观看 | 深夜爽爽爽福利动态图 | 99热播| 欧美一级特黄aaa大片 | 久久99精品久久只有精品 | 精品国产一二三区在线影院 | 色内内免费视频播放 | 日韩色在线 | 日本美女视频韩国视频网站免费 | 欧美日韩国产一区三区 | 国产一及毛片 | 天天激情站 | 韩国精品一区二区三区四区五区 | 精品国产成a人在线观看 | 国产精品亚洲一区二区在线观看 | 亚洲qingse中文久久网 |